HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
Literature
- <em>Drosophila melanogaster</em> as a model to study autophagy in neurodegenerative diseases induced by proteinopathies
- Age-dependent increase in tau phosphorylation at serine 396 in Huntington s disease pre-frontal cortex
- Nursing home residents with Huntington's disease: Heterogeneity in characteristics and functioning
- Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review
- Mutant Huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
News
- Obituary: Marilyn Anthony VanPatten - Columbia Gorge News
- Huntington's Disease Chorea Improved With Valbenazine | MedPage Today
- Teva Pharmaceutical Industries Limited [TEVA] Is Currently 0.42 below its 200 Period Moving Avg
- Huntington's Disease Treatment Market 2023 Comprehensive Analysis, Business Growing ...
- SUNY Oswego Student Entrepreneurs' Assistive Gaming Technology Places Second In ...